172 related articles for article (PubMed ID: 28448783)
21. Current Procedural Terminology Codes for Medication Therapy Management in Administrative Data.
Axon DR; Chinthammit C; Tate J; Taylor AM; Leal S; Pickering M; Black H; Warholak T; Campbell PJ
J Manag Care Spec Pharm; 2020 Oct; 26(10):1297-1300. PubMed ID: 32996390
[TBL] [Abstract][Full Text] [Related]
22. Nationwide estimates of medication therapy management delivery under the Medicare prescription drug benefit.
Pestka DL; Zillich AJ; Coe AB; Farris KB; Adeoye OA; Snyder ME; Farley JF
J Am Pharm Assoc (2003); 2020; 60(3):456-461. PubMed ID: 31926872
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of Comprehensive Medication Review Completion Rates Using 3 Patient Outreach Models.
Miller DE; Roane TE; Salo JA; Hardin HC
J Manag Care Spec Pharm; 2016 Jul; 22(7):796-800. PubMed ID: 27348280
[TBL] [Abstract][Full Text] [Related]
24. Pharmacists' acceptable levels of compensation for MTM services: a conjoint analysis.
Wang J; Hong SH; Meng S; Brown LM
Res Social Adm Pharm; 2011 Dec; 7(4):383-95. PubMed ID: 21272533
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of a Pharmacist-Managed Diabetes Program in a Primary Care Setting Within an Integrated Health Care System.
Benedict AW; Spence MM; Sie JL; Chin HA; Ngo CD; Salmingo JF; Vidaurreta AT; Rashid N
J Manag Care Spec Pharm; 2018 Feb; 24(2):114-122. PubMed ID: 29384029
[TBL] [Abstract][Full Text] [Related]
26. Understanding the Socioeconomic and Geographical Characteristics of Beneficiaries Receiving a Comprehensive Medication Review.
Chou J; Pellegrin K; Cooke CE; Zarowitz B; Hanlon A; Lozano A; Brandt NJ
J Manag Care Spec Pharm; 2020 Oct; 26(10):1276-1281. PubMed ID: 32996388
[TBL] [Abstract][Full Text] [Related]
27. Effect of Clinical and Attitudinal Characteristics on Obtaining Comprehensive Medication Reviews.
Farris KB; Salgado TM; Aneese N; Marshall VD; Pendergast JF; Frank J; Chrischilles EA; Doucette WR
J Manag Care Spec Pharm; 2016 Apr; 22(4):388-95. PubMed ID: 27023692
[TBL] [Abstract][Full Text] [Related]
28. Medication Nonadherence Among Medicare Beneficiaries with Comorbid Chronic Conditions: Influence of Pharmacy Dispensing Channel.
Iyengar RN; LeFrancois AL; Henderson RR; Rabbitt RM
J Manag Care Spec Pharm; 2016 May; 22(5):550-60. PubMed ID: 27123916
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of a pharmacist-driven medication adherence enhancement service.
Rinehart SN; Collins C; Glover J; Rice WM
J Manag Care Spec Pharm; 2021 Apr; 27(4):507-515. PubMed ID: 33769859
[No Abstract] [Full Text] [Related]
30. Factors affecting demand among older adults for medication therapy management services.
Brooks JM; Unni EJ; Klepser DG; Urmie JM; Farris KB; Doucette WR
Res Social Adm Pharm; 2008 Dec; 4(4):309-19. PubMed ID: 19064238
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of Eligibility Criteria Used to Identify Patients for Medication Therapy Management Services: A Retrospective Cohort Study in a Medicare Advantage Part D Population.
Lee JS; Yang J; Stockl KM; Lew H; Solow BK
J Manag Care Spec Pharm; 2016 Jan; 22(1):22-30. PubMed ID: 27015048
[TBL] [Abstract][Full Text] [Related]
32. Perceptions and experiences of promotoras and pharmacists in an academic-community partnership providing telephonic MTM services to a Spanish-speaking, rural population: a focus group study.
Guerra B; Vaffis S; Axon DR; Leal S; Warholak T; Taylor AM; Scovis N
J Manag Care Spec Pharm; 2020 Nov; 26(11):1390-1397. PubMed ID: 33119436
[No Abstract] [Full Text] [Related]
33. Findings from a National Survey of Medicare Beneficiary Perspectives on the Medicare Part D Medication Therapy Management Standardized Format.
Brandt NJ; Cooke CE; Sharma K; Chou J; Carden MJ; Kumbera P; Pellegrin K
J Manag Care Spec Pharm; 2019 Mar; 25(3):366-391. PubMed ID: 30816816
[TBL] [Abstract][Full Text] [Related]
34. A Comparison of Pharmacy Dispensing Channel Use and Adherence to Specialty Drugs Among Medicare Part D Beneficiaries.
Kale HP; Patel AM; Carroll NV
J Manag Care Spec Pharm; 2018 Apr; 24(4):317-326. PubMed ID: 29578855
[TBL] [Abstract][Full Text] [Related]
35. Factors affecting Medicare Part D beneficiaries' decision to receive comprehensive medication reviews.
Doucette WR; Zhang Y; Chrischilles EA; Pendergast JF; Newland BA; Farris KB; Frank J
J Am Pharm Assoc (2003); 2013; 53(5):482-7. PubMed ID: 24030125
[TBL] [Abstract][Full Text] [Related]
36. An advanced pharmacy practice experience in a student-staffed medication therapy management call center.
Hardin HC; Hall AM; Roane TE; Mistry R
Am J Pharm Educ; 2012 Aug; 76(6):110. PubMed ID: 22919086
[TBL] [Abstract][Full Text] [Related]
37. Comparison of Medication Therapy Management Services and Their Effects on Health Care Utilization and Medication Adherence.
Ferries E; Dye JT; Hall B; Ndehi L; Schwab P; Vaccaro J
J Manag Care Spec Pharm; 2019 Jun; 25(6):688-695. PubMed ID: 31134865
[TBL] [Abstract][Full Text] [Related]
38. Design of the POINT study: Pharmacotherapy Optimisation through Integration of a Non-dispensing pharmacist in a primary care Team (POINT).
Hazen AC; Sloeserwij VM; Zwart DL; de Bont AA; Bouvy ML; de Gier JJ; de Wit NJ; Leendertse AJ
BMC Fam Pract; 2015 Jul; 16():76. PubMed ID: 26135582
[TBL] [Abstract][Full Text] [Related]
39. Associations Between Chronic Disease, Polypharmacy, and Medication-Related Problems Among Medicare Beneficiaries.
Almodóvar AS; Nahata MC
J Manag Care Spec Pharm; 2019 May; 25(5):573-577. PubMed ID: 31039057
[TBL] [Abstract][Full Text] [Related]
40. Risk of Nondherence to Diabetes Medications Among Medicare Advantage Enrollees: Development of a Validated Risk Prediction Tool.
Mhatre SK; Serna O; Sansgiry S; Fleming ML; Essien EJ; Sansgiry SS
J Manag Care Spec Pharm; 2016 Nov; 22(11):1293-1301. PubMed ID: 27783546
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
